Early Colorectal Cancers Provide New Evidence for a Lynch Syndrome-to-CMMRD Phenotypic Continuum

Cancers
Ceres Fernandez-RozadillaClara Ruiz-Ponte

Abstract

Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome, caused by heterozygous mutations in the mismatch repair (MMR) genes. Biallelic mutations in these genes lead however, to constitutive mismatch repair deficiency (CMMRD). In this study, we follow the diagnostic journey of a 12-year old patient with CRC, with a clinical phenotype overlapping CMMRD. We perform molecular and functional assays to discard a CMMRD diagnosis then identify by exome sequencing and validation in a cohort of 134 LS patients, a candidate variant in the MLH1 UTR region in homozygosis. We propose that this variant, together with other candidates, could be responsible for age-of-onset modulation. Our data support the idea that low-risk modifier alleles may influence early development of cancer in LS leading to a LS-to-CMMRD phenotypic continuum. Therefore, it is essential that larger efforts are directed to the identification and study of these genetic modifiers, in order to provide optimal cancer prevention strategies to these patients.

References

Mar 7, 2003·The New England Journal of Medicine·Henry T Lynch, Albert de la Chapelle
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Loïc Le MarchandBrian E Henderson
Jan 19, 2006·Journal of the National Cancer Institute·Maja ZecevicMarsha L Frazier
Jun 10, 2009·Bioinformatics·Heng LiUNKNOWN 1000 Genome Project Data Processing Subgroup
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Clay E S ComstockKaren E Knudsen
Jan 9, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·A Joan LevineRobert W Haile
Nov 26, 2010·Journal of Human Genetics·Carolina BonillaWalter F Bodmer
Mar 17, 2011·European Journal of Human Genetics : EJHG·Solene HoulleThierry Frebourg
Aug 9, 2011·BMC Cancer·Anna AbulíUNKNOWN Gastrointestinal Oncology Group of the Spanish Gastroenterological Association
Sep 21, 2012·BMC Bioinformatics·Emanuele RaineriMiguel Pérez-Enciso
Mar 25, 2014·Current Opinion in Genetics & Development·Ludmil B Alexandrov, Michael R Stratton
Apr 17, 2014·Journal of Medical Genetics·Katharina WimmerUNKNOWN EU-Consortium Care for CMMRD (C4CMMRD)
Dec 15, 2015·JAMA Oncology·James WhitworthEamonn R Maher
Jan 15, 2016·Molecular Biology and Evolution·Joaquín DopazoGuillermo Antiñolo
Feb 24, 2016·PLoS Genetics·Richarda M de VoerRoland P Kuiper
May 12, 2016·European Journal of Human Genetics : EJHG·Clara Esteban-JuradoSergi Castellví-Bel
Mar 18, 2017·Epigenetics : Official Journal of the DNA Methylation Society·Andrea J Savio, Bharati Bapat
Dec 7, 2018·Translational Lung Cancer Research·Michael AllgäuerAlbrecht Stenzinger

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

eDiVa

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Related Papers

JAMA : the Journal of the American Medical Association
Leticia MoreiraEPICOLON Consortium
Cirugía española
Manuel Ferrer MárquezMaría del Mar Rico Morales
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Christoph EngelHans F A Vasen
© 2021 Meta ULC. All rights reserved